Previous studies have reported that the gene variations in EGF, TGFA, and EGFR can lead to deregulation of the EGFR pathway and overexpression of EGF, TGF-α, and EGFR proteins [27–30], which are associated with GC and various malignancies [31, 32]. This evidence concerns the gene TGFA and gastric cancer.